Mihaela Diaconu

Mihaela Diaconu

Auto-generated profile, based on publicly available information

Mihaela Diaconu

Mei-Chih Liao, Mihaela Diaconu, Ahmed Mansouri, Department of Molecular Cell Biology, Max-Planck-Institute for Biophysical Chemistry, 37077 Göttingen, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Cell
Verified
Journal Article
Closed access
MDMihaela Diaconu
Mihaela Diaconu
Ute KotheUte Kothe
Ute Kothe
FSFrank Schlünzen
Frank Schlünzen
NFNiels Fischer
Niels Fischer
JHJörg M. Harms
Jörg M. Harms
MWMarkus C. Wahl
Markus C. Wahl

23 February 2004 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
KNKarim Nayernia
Karim Nayernia
MDMihaela Diaconu
Mihaela Diaconu
GAGerhard Aumüller
Gerhard Aumüller
Gunther WennemuthGunther Wennemuth
Gunther Wennemuth
ISIris Schwandt
Iris Schwandt
WEWolfgang Engel
Wolfgang Engel

10 July 2006 in Andrologia
Verified
Journal Article
Closed access
PDF file
MDM. Diaconu
M. Diaconu
YTY. Tangat
Y. Tangat
DBD. Bohm
D. Bohm
HKH. Kuhn
H. Kuhn
HMH. W. Michelmann
H. W. Michelmann
KNK. Nayernia
K. Nayernia
Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a selenoprotein belonging to the family of glutathione peroxidases. PHGPx has long been considered a major antioxidant that, in cooperation with vitamin E, protects biomembranes. To determine the expression pattern of PHGPx mRNA in human, quantitative RT‐polymerase chain reaction (PCR) analyses using RNA from different embryonal and adult tissues were performed. A predominant expression was found in testes. In spermatozoa, PHGPx was found to be localized in the mid‐piece of spermatozoa. We studied the relationship between spermatozoa PHGPx expression, mutations in PHGPx gene and human oligoasthenozoospermia, a defect in which both the number and the motility of spermatozoa are significantly below normal. Spermatozoa specimens from 45 infertile males were analysed for fertility‐related parameters according to World Health Organisation and were classified as suffering from oligoasthenozoospermia. Two patients (4.44%) showed no expression of PHGPx and in nine patients (20.00%), a reduced expression of the enzyme was observed. DNA sequences of various regions of the PHGPx gene (coding, 5′flanking region and intron 1) from these patients and 58 fertile volunteers were analysed for mutations by PCR amplification and direct sequencing. Sequence data revealed no cause/effect relationship for any of the variants. From these data it can be concluded that oligoasthenozoospermia is associated with a decrease in the level of expression of PHGPx in the spermatozoa of some infertile men (24.44%), but is not linked to mutations in PHGPx gene.

1 January 2005 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CHConstantina Heltianu
Constantina Heltianu
GCGabriela Costache
Gabriela Costache
AGAnca Gafencu
Anca Gafencu
MDMihaela Diaconu
Mihaela Diaconu
MBMihaela Bodeanu
Mihaela Bodeanu
MSMaya Simionescu
Maya Simionescu
The endothelial cell (EC) dysfunction is a common characteristic of various pathologies that include atherosclerosis, hypertension, and Fabry's disease. Aware of the role of eNO and ACE in EC dysfunction, we questioned whether polymorphism of eNOS and/or ACE gene may be a common denominator in these pathologies. Patients with CHD (108), HT (109), Fabry's disease (37) and healthy subjects (control, 141) were genotyped for the eNOSG894T by RFLP-PCR technique and for eNOS4b/a, and ACEI/D polymorphisms by PCR amplification. The results of these studies were statistically evaluated. Compared to controls, the frequency of the eNOSG894T (T allele) was higher in CHD (P=0.03) and Fabry (P=0.01), while the eNOS4b/a (a allele) in CHD (P=0.01) and HT patients (P=0.01). The proportion of the ACEI/D was similar in all subjects. In CHD patients at “low risk” of atherogenic factors, the frequency of the T and a alleles of eNOS gene was high (P=0.03 and 0.02, respectively). Carriers of the T allele of eNOSG894T were over-represented (P=0.04) in Fabry subgroup with renal failure. Compared to women, the eNOS894T alleles were more frequent (P=0.03) in men with CHD and HT, whereas ACE I/D in men (P=0.03) with HT. These findings suggest: (i) the frequency of eNOSG894T and/or eNOS4b/a is significantly associated with coronary dysfunction; (ii) eNOS4b/a confers a relatively high risk of hypertension in subjects with atherogenic risk factors; (iii) the frequency of eNOSG894T is high in Fabry hemizygotes with renal complications. Therefore, eNOS gene polymorphism represent a frequent risk factor for vascular abnormalities in CHD, HT and Fabry's disease, afflictions which have in common, the endothelial dysfunction.

1 June 2011 in Gene Expression Patterns
Verified
Journal Article
Closed access
GGGundula Griesel
Gundula Griesel
CKChristian Krug
Christian Krug
LYLarisa Yurlova
Larisa Yurlova
MDMihaela Diaconu
Mihaela Diaconu
AMAhmed Mansouri
Ahmed Mansouri

1 January 2014 in World Journal of Stem Cells
Verified
Journal Article
Open access
MLMei-Chih Liao
Mei-Chih Liao
MDMihaela Diaconu
Mihaela Diaconu
SMSebastian Monecke
Sebastian Monecke
PCPatrick Collombat
Patrick Collombat
CTCharles Timaeus
Charles Timaeus
AMAhmed Mansouri
Ahmed Mansouri
AIM: To find a safe source for dopaminergic neurons, we generated neural progenitor cell lines from human embryonic stem cells. METHODS: The human embryonic stem (hES) cell line H9 was used to generate human neural progenitor (HNP) cell lines. The resulting HNP cell lines were differentiated into dopaminergic neurons and analyzed by quantitative real-time polymerase chain reaction and immunofluorescence for the expression of neuronal differentiation markers, including beta-III tubulin (TUJ1) and tyrosine hydroxylase (TH). To assess the risk of teratoma or other tumor formation, HNP cell lines and mouse neuronal progenitor (MNP) cell lines were injected subcutaneously into immunodeficient SCID/beige mice. RESULTS: We developed a fairly simple and fast protocol to obtain HNP cell lines from hES cells. These cell lines, which can be stored in liquid nitrogen for several years, have the potential to differentiate in vitro into dopaminergic neurons. Following day 30 of differentiation culture, the majority of the cells analyzed expressed the neuronal marker TUJ1 and a high proportion of these cells were positive for TH, indicating differentiation into dopaminergic neurons. In contrast to H9 ES cells, the HNP cell lines did not form tumors in immunodeficient SCID/beige mice within 6 mo after subcutaneous injection. Similarly, no tumors developed after injection of MNP cells. Notably, mouse ES cells or neuronal cells directly differentiated from mouse ES cells formed teratomas in more than 90% of the recipients. CONCLUSION: Our findings indicate that neural progenitor cell lines can differentiate into dopaminergic neurons and bear no risk of generating teratomas or other tumors in immunodeficient mice.